The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations

Autor: Thao P. T. Doan, Paola Tarchi, Caecilia H. C. Sukowati, Loraine Kay D. Cabral, An B. Luong, Deborah Bonazza, Huy Q. Do, Claudio Tiribelli, Hoa L. T. Pham, Lory Saveria Crocè, Long D. C. Tran, Cristina Bottin
Přispěvatelé: Luong, A. B., Do, H. Q., Tarchi, P., Bonazza, D., Bottin, C., Cabral, L. K. D., Tran, L. D. C., Doan, T. P. T., Croce, L. S., Pham, H. L. T., Tiribelli, C., Sukowati, C. H. C.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
cancer stem cells
Male
Pathology
medicine.medical_treatment
Messenger
hepatocellular carcinoma
mRNA expression
Aged
Biomarkers
Tumor

Carcinoma
Hepatocellular

Cohort Studies
Female
Gene Expression Regulation
Neoplastic

Hepatitis B
Humans
Liver Neoplasms
Middle Aged
Neoplastic Stem Cells
Prognosis
RNA
Messenger

Thy-1 Antigens
0302 clinical medicine
Gene expression
lcsh:QH301-705.5
Tumor
medicine.diagnostic_test
Incidence (epidemiology)
General Medicine
Liver Neoplasm
030220 oncology & carcinogenesis
Hepatocellular carcinoma
030211 gastroenterology & hepatology
Human
medicine.medical_specialty
cancer stem cell
Prognosi
Biology
Immunofluorescence
Article
03 medical and health sciences
Cancer stem cell
medicine
CD90
Neoplastic
Messenger RNA
Carcinoma
Hepatocellular
medicine.disease
digestive system diseases
Gene Expression Regulation
lcsh:Biology (General)
RNA
Neoplastic Stem Cell
Hepatectomy
Cohort Studie
Biomarkers
Zdroj: Cells
Volume 9
Issue 12
Cells, Vol 9, Iss 2672, p 2672 (2020)
Popis: Epidemiology of hepatocellular carcinoma (HCC) showed a correlation between incidence and geographical-relevant risk factors. This study aims to compare the distributions of cancer stem cells (CSC) in two distant populations in Asia and Europe. We analyzed 52 and 43 selected HCC patients undergoing hepatectomy in Ho Chi Minh City (Vietnam) and Trieste (Italy). Each patient sample consisted of HCC, peri-HCC, and non-tumoral (distal) tissue. Demographic data were recorded together with clinical findings. The protocol for the collection of tissue samples and RNA was standardized in both laboratories and gene expression analysis was performed in a single laboratory with identical PCR conditions. Baseline data showed comparable laboratory findings between the two cohorts. mRNA distribution showed a comparable pattern of all CSC markers analyzed with the expression of CD90 progressively increasing from distal and peri-HCC to be highest in HCC (p <
0.001), confirmed by immunofluorescence data. CD90 mRNA distribution was related to HBV-related HCC and a tumor diameter less than 5 cm. Patients with high tumoral CD90 mRNA had a shorter time (p <
0.05) to tumor recurrence compared to patients with lower CD90. This comparative study showed that CD90 mRNA expressions are comparable between Eastern and Western HCC cases.
Databáze: OpenAIRE